Literature DB >> 10508212

Proton magnetic resonance assay of total and taurine-conjugated bile acids in bile.

H Ishikawa1, T Nakashima, K Inaba, H Mitsuyoshi, Y Nakajima, Y Sakamoto, T Okanoue, K Kashima, Y Seo.   

Abstract

Biliary bile acids, coexisting with phospholipid and cholesterol, are partly conjugated with taurine. In the present report we show that total and taurine-conjugated bile acids in bile can be simultaneously and quantitatively measured by high-resolution (1)H-nuclear magnetic resonance ((1)H-NMR) spectroscopy. We used a 7.05-Tesla NMR spectrometer to obtain the (1)H-NMR spectra of model and biological biles. Only addition of trimethylsilyl-3-propionic acid sodium salt-D(4) (TSP) to each sample as an internal standard was required in preparation for (1)H-NMR measurement. In (1)H-NMR spectra of rat bile, peaks of C-18 methyl protons of bile acids and of C-25 methylene protons on the taurine moiety of taurine-conjugated bile acids were detected at 0.7 ppm and 3.1 ppm, respectively. Peak areas, of C-18 and C-25 peaks, increased in proportion to the concentrations of bile acids or taurine-conjugated bile acids, even in the presence of phospholipid and cholesterol. The accuracy of NMR measurement of total and taurine-conjugated bile acids was confirmed by comparing the results of NMR with those of enzyme-fluorimetry. The results clearly demonstrate that (1)H-NMR spectroscopy can be applied to the quantitative determination of total and taurine-conjugated bile acids in bile without troublesome preparative steps.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508212

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 2.  A review of analytical platforms for accurate bile acid measurement.

Authors:  Mainak Dutta; Jingwei Cai; Wei Gui; Andrew D Patterson
Journal:  Anal Bioanal Chem       Date:  2019-05-24       Impact factor: 4.142

3.  Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.

Authors:  Mohamed S Hashim Abdalla; Simon D Taylor-Robinson; Amar W Sharif; Horace R T Williams; Mary M E Crossey; Gamal A Badra; Andrew V Thillainayagam; Devinder S Bansi; Howard C Thomas; Imam A Waked; Shahid A Khan
Journal:  HPB (Oxford)       Date:  2011-03-22       Impact factor: 3.647

4.  One-step analysis of major bile components in human bile using 1H NMR spectroscopy.

Authors:  G A Nagana Gowda; B S Somashekar; Omkar B Ijare; Ajay Sharma; V K Kapoor; C L Khetrapal
Journal:  Lipids       Date:  2006-06       Impact factor: 1.880

5.  Interaction of bile salt and phospholipids with bovine submaxillary mucin.

Authors:  T S Wiedmann; C Deye; D Kallick
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

6.  Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy.

Authors:  Amar W Sharif; Horace R T Williams; Temi Lampejo; Shahid A Khan; Devinder S Bansi; David Westaby; Andrew V Thillainayagam; Howard C Thomas; I Jane Cox; Simon D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

7.  Sesquiterpene lactone! a promising antioxidant, anticancer and moderate antinociceptive agent from Artemisia macrocephala jacquem.

Authors:  Mohammad Shoaib; Ismail Shah; Niaz Ali; Achyut Adhikari; Muhammad Nawaz Tahir; Syed Wadood Ali Shah; Saiqa Ishtiaq; Jahangir Khan; Shahzeb Khan; Mohammad Naveed Umer
Journal:  BMC Complement Altern Med       Date:  2017-01-07       Impact factor: 3.659

8.  Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes.

Authors:  Daniel Sachse; Line Sletner; Kjersti Mørkrid; Anne Karen Jenum; Kåre I Birkeland; Frode Rise; Armin P Piehler; Jens Petter Berg
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.